Avoro Capital Advisors LLC grew its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 9.9% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,111,111 shares of the biopharmaceutical company’s stock after purchasing an additional 100,000 shares during the quarter. Alnylam […]